Patent Assignment
Reel/Frame 051231/0961
Notice of Grant of Security Interest in Intellectual Property
Recorded: 2019-12-09
Pages: 13
Assignors
MALLINCKRODT LLC
Executed: 2019-12-09
OCERA THERAPEUTICS, INC.
Executed: 2019-12-09
MALLINCKRODT ARD IP LIMITED
Executed: 2019-12-09
MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
Executed: 2019-12-09
SPECGX LLC
Executed: 2019-12-09
STRATATECH CORPORATION
Executed: 2019-12-09
VTESSE INC.
Executed: 2019-12-09
MALLINCKRODT PHARMA IP TRADING D.A.C.
Executed: 2019-12-09
Assignee
DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
60 WALL STREET, NEW YORK, NEW YORK, 10005
Covered Properties
(42)
(+)-Morphinans as Antagonists of Toll-Like Receptor 9 and Therapeutic Uses Thereof
Macrocyclic Ghrelin Receptor Modulators and Methods of Using the Same
L-Ornithine Phenyl Acetate and Methods of Making Thereof
Combinational Liposome Compositions for Cancer Therapy
Treatment and Prevention of Neuronal Cell Loss Using L-Ornithine in Combination with at Least One of Phenylacetate and Phenylbutyrate
Application:
15/751,442 →
Publication:
US 2020/0206174
Treatment of Portal Hypertension and Restoration of Liver Function Using L-Ornithine Phenylacetate
Macrocyclic Ghrelin Receptor Modulators and Methods of Using the Same
Use of Human Skin Substitutes Expressing Exogenous Il-12 to Treat a Wound Bed
Methods For Treating Hyperbilirubinemia With Stannsoporfin And Phototherapy
Application:
16/300,362 →
Publication:
US 2020/0001109
Devices and Methods for Monitoring Oxygenation Uring Treatment with Delivery of Nitric Oxide
Application:
16/365,263 →
Publication:
US 2019/0216377
Acth Prophylactic Treatment of Renal Disorders
Application:
16/369,690 →
Publication:
US 2019/0216901
Hydroxypropyl Beta-Cyclodextrin Compositions and Methods
Methods of Administering Inhaled Nitric Oxide Gas
Powder Formulation
Application:
16/408,678 →
Publication:
US 2019/0269764
Method of Treating Patients with Hepatorenal Syndrome Type 1
Application:
16/411,944 →
Publication:
US 2019/0328831
Hydroxypropyl Beta-Cyclodextrin Compositions and Methods
Tissue Container Systems
Systems and Methods for Manufacturing and Safety of an NO2-to-No Reactor Cartridge Used to Deliver No for Inhalation Therapy to a Patient
Therapeutic Gas Delivery Device With Pulsed And Continuous Flow Control
Methods for Treating Hyperbilirubinemia with Stannsoporfin
Application:
16/505,295 →
Publication:
US 2020/0016167
Zero-Order Modified Release Solid Dosage Forms
Application:
16/529,323 →
Publication:
US 2019/0358164
Centrifuge System and Method with Component Tracking
Patent:
11,020,522 →
Application:
16/537,103 →
Apparatus and Method for Monitoring Nitric Oxide Delivery
Systems and Methods for High Humidity Curing Within Tablet Coating System
Abuse Deterrent Immediate Release Capsule Dosage Forms
Compensating for Disruptions in Breathing Gas Flow Measurement
Extended Release, Abuse Deterrent Pharmaceutical Compositions
Processes of Making L-Ornithine Phenylacetate
Apparatus and Method for Humidity Conditioning Sample Gas of a Patient Breathing Circuit Affiliated with a Ventilator and/or Nitric Oxide Delivery System
Method of Treating Patients with Hepatorenal Syndrome Type 1
Application:
16/669,151 →
Publication:
US 2020/0046798
Clinical Decision Support System and Methods
Self-Contained Gas Sensor Module
Application:
62/774,687 →
Methods of Promoting Remyelination
Application:
62/789,016 →
Acthar Gel's Impact on Corticosterone
Application:
62/794,369 →
Gas Delivery System
Application:
62/823,297 →
Methods of Assessing Hepatic Encephalopathy
Application:
62/845,569 →
Methods to Increase Functional Capacity and Quality of Life in Bronchiectasis Patients with Nontuberculous Mycobacteria
Application:
62/849,064 →
Methods of Promoting Remyelination
Application:
62/852,097 →
Methods for Treating Acute Wounds and Improving Outcomes in Subjects Less Than 18 Years of Age or Greater Than 65 Years of Age
Application:
62/907,308 →
Methods for Treating Acute Wounds and Improving Outcomes
Application:
62/910,887 →
Dosages of L-Ornithine Phenylacetate for Treating Hyperammonemia
Application:
62/916,159 →
Method of Treating Patients with Hepatorenal Syndrome Type 1 and Low Mean Arterial Pressure
Application:
62/928,152 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Non-Competition, Non-Solicitation, and Confidentiality Agreement
Dec 6, 2016
From: BERBERICH, DAVID W.
To: MALLINCKRODT LLC
Reel/Frame 040824/0650 →
Assignment of Assignor's Interest
Dec 6, 2016
From: TRAWICK, BOBBY N.; GROTE, CHRISTOPHER W.
To: MALLINCKRODT LLC
Reel/Frame 040539/0190 →
Assignment of Assignor's Interest
Jun 6, 2018
From: YANG, JUN; WU, STEPHEN H.; HERMAN, CLIFF J.
To: MALLINCKRODT LLC
Reel/Frame 045998/0272 →
Assignment of Assignor's Interest
Nov 30, 2018
From: JALAN, RAJIV
To: UCL BUSINESS PLC
Reel/Frame 047643/0444 →
Assignment of Assignor's Interest
Nov 30, 2018
From: ANDERSON, KEITH
To: OCERA THERAPEUTICS, INC.
Reel/Frame 047643/0211 →
Assignment of Assignor's Interest
Apr 9, 2019
From: INO THERAPEUTICS LLC
To: THERAKOS, INC.
Reel/Frame 048831/0888 →
Assignment of Assignor's Interest
Apr 9, 2019
From: MALLINCKRODT PHARMA IP TRADING DAC
To: MALLINCKRODT IP
Reel/Frame 048832/0376 →
Assignment of Assignor's Interest
Apr 9, 2019
From: BALDASSARRE, JAMES S.
To: IKARIA HOLDINGS, INC.
Reel/Frame 048831/0519 →
Assignment of Assignor's Interest
Apr 9, 2019
From: MALLINCKRODT IP
To: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
Reel/Frame 048832/0665 →
Change of Name
Apr 9, 2019
From: IKARIA HOLDINGS, INC.
To: IKARIA, INC.
Reel/Frame 048833/0631 →
Assignment of Assignor's Interest
Apr 9, 2019
From: MALLINCKRODT CRITICAL CARE FINANCE INC.
To: MALLINCKRODT PHARMA IP TRADING DAC
Reel/Frame 048832/0038 →
Assignment of Assignor's Interest
Apr 9, 2019
From: THERAKOS, INC.
To: MALLINCKRODT CRITICAL CARE FINANCE INC.
Reel/Frame 048832/0962 →
Change of Name
Apr 9, 2019
From: IKARIA, INC.
To: INO THERAPEUTICS LLC
Reel/Frame 048831/0770 →
Nunc Pro Tunc Assignment
May 24, 2019
From: MALLINCKRODT PHARMA IP TRADING D.A.C.
To: MALLINCKRODT IP UNLIMITED COMPANY
Reel/Frame 049274/0954 →
Nunc Pro Tunc Assignment
May 24, 2019
From: INFACARE PHARMACEUTICAL CORPORATION
To: MALLINCKRODT PHARMA IP TRADING D.A.C.
Reel/Frame 049274/0943 →
Nunc Pro Tunc Assignment
May 24, 2019
From: MALLINCKRODT IP UNLIMITED COMPANY
To: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
Reel/Frame 049274/0983 →
Notice of Grant of Security Interest in Intellectual Property
Jul 22, 2019
From: OCERA THERAPEUTICS
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 049823/0220 →
Notice of Grant of Security Interest in Intellectual Property
Jul 22, 2019
From: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 049822/0674 →
Change of Name
Nov 27, 2019
From: UCL BUSINESS PLC
To: UCL BUSINESS LTD
Reel/Frame 051144/0324 →
Security Interest
Dec 10, 2019
From: MALLINCKRODT ARD IP LIMITED; MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 051256/0829 →
Assignment of Assignor's Interest
Mar 26, 2021
From: ROSE, CHRISTOPHER F.; CLÉMENT, MARC-ANDRÉ; BOSOI, CRISTINA R.; OLIVEIRA, MARIANA MACEDO
To: OCERA THERAPEUTICS, INC.
Reel/Frame 055733/0984 →
Change of Name
Jun 3, 2021
From: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
To: MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY
Reel/Frame 056476/0162 →
Assignment of Assignor's Interest
Jun 3, 2021
From: MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY
To: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 056433/0640 →
Assignment of Assignor's Interest
Jul 15, 2021
From: VTESSE LLC
To: MANDOS LLC
Reel/Frame 056872/0369 →
Assignment of Assignor's Interest
Sep 9, 2021
From: KOEPSEL, JUSTIN; GRATZ, KEN
To: STRATATECH CORPORATION
Reel/Frame 057433/0645 →